New insights into the pharmacokinetics and pharmacodynamics of natalizumab treatment for patients with multiple sclerosis, obtained from clinical and in vitro studies
Crossref DOI link: https://doi.org/10.1186/s12974-016-0635-2
Published Online: 2016-06-27
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sehr, T.
Proschmann, U.
Thomas, K.
Marggraf, M.
Straube, E.
Reichmann, H.
Chan, A.
Ziemssen, T. http://orcid.org/0000-0001-8799-8202